MELLETT PAUL J 4
4 · ENANTA PHARMACEUTICALS INC · Filed Jan 10, 2023
Insider Transaction Report
Form 4
MELLETT PAUL J
Treasurer and CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-01-09−2,812→ 0 totalExercise: $14.18Exp: 2023-01-17→ Common Stock (2,812 underlying) - Exercise/Conversion
Common Stock
2023-01-09$14.18/sh+2,812$39,874→ 88,463 total
Footnotes (1)
- [F1]100% of the shares subject to the option are fully vested and exercisable.